MedPath
HSA Approval

SHINTAMET INJECTION 150 mg/ml

SIN07894P

SHINTAMET INJECTION 150 mg/ml

SHINTAMET INJECTION 150 mg/ml

October 31, 1994

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

A02BA01

cimetidine

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL IND CO LTD

Active Ingredients

CIMETIDINE

150 mg/ml

Cimetidine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SHINTAMET INJECTION 150 mg/ml - HSA Approval | MedPath